Developed in partnership with TriReme’s subsidiary, Quattro Vascular in Singapore, Chocolate balloon catheter will facilitate the formation of small modules, reducing shear stress and allowing for uniform inflation and rapid deflation.
TriReme president and CEO Eitan Konstantino said Chocolate is an addition to their line of proprietary peripheral catheters, and hope that Chocolate will provide substantial clinical benefits to patients suffering from peripheral vascular disease, both above and below the knee.
Metro Health Hospital in Wyoming, Michigan, US Endovascular Interventions and Research director Jihad Mustapha said they treated complex occlusions with outstanding results, no elastic recoil and no dissections using the Chocolate PTA balloon catheter.
Based in California, TriReme Medical is a privately held medical device company focussed on the development, manufacturing, and commercialization of next generation percutaneous devices for the treatment of complex coronary and peripheral arterial disease.
